Show simple item record

dc.contributor.authorParker, EPen_US
dc.contributor.authorRamani, Sen_US
dc.contributor.authorLopman, BAen_US
dc.contributor.authorChurch, JAen_US
dc.contributor.authorIturriza-Gómara, Men_US
dc.contributor.authorPrendergast, AJen_US
dc.contributor.authorGrassly, NCen_US
dc.date.accessioned2018-03-05T10:32:39Z
dc.date.available2017-09-17en_US
dc.date.issued2018-01en_US
dc.date.submitted2018-02-27T08:56:44.566Z
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/34265
dc.description.abstractOral vaccines are less immunogenic when given to infants in low-income compared with high-income countries, limiting their potential public health impact. Here, we review factors that might contribute to this phenomenon, including transplacental antibodies, breastfeeding, histo blood group antigens, enteric pathogens, malnutrition, microbiota dysbiosis and environmental enteropathy. We highlight several clear risk factors for vaccine failure, such as the inhibitory effect of enteroviruses on oral poliovirus vaccine. We also highlight the ambiguous and at times contradictory nature of the available evidence, which undoubtedly reflects the complex and interconnected nature of the factors involved. Mechanisms responsible for diminished immunogenicity may be specific to each oral vaccine. Interventions aiming to improve vaccine performance may need to reflect the diversity of these mechanisms.en_US
dc.description.sponsorshipEPK Parker has received funding from the UK Medical Research Council. M Iturriza-Gómara has received research grant support form GlaxoSmithKline and Sanofi Pasteur MSD.en_US
dc.format.extent97 - 118en_US
dc.languageengen_US
dc.language.isoenen_US
dc.relation.ispartofFuture Microbiolen_US
dc.rightsThis work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
dc.subjectcholeraen_US
dc.subjectenteropathyen_US
dc.subjecthisto blood group antigensen_US
dc.subjectimmunogenicityen_US
dc.subjectmalnutritionen_US
dc.subjectmicrobiotaen_US
dc.subjectoral vaccinesen_US
dc.subjectpoliovirusen_US
dc.subjectrotavirusen_US
dc.subjectAdministration, Oralen_US
dc.subjectAntibodiesen_US
dc.subjectDeveloping Countriesen_US
dc.subjectHumansen_US
dc.subjectVaccinesen_US
dc.titleCauses of impaired oral vaccine efficacy in developing countries.en_US
dc.typeArticle
dc.identifier.doi10.2217/fmb-2017-0128en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/29218997en_US
pubs.notesNo embargoen_US
pubs.notesPublished as open access manuscript with weblink aboveen_US
pubs.publication-statusPublisheden_US
pubs.volume13en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record